Latest filing published 30 Jul 2026 for PTC Therapeutics, INC..
Insider track record
No signal scores available.
Hege Elisabeth Sollie-Zetlmayer: trading record in brief
All filings by Hege Elisabeth Sollie-Zetlmayer on record concern PTC Therapeutics, Inc. Altogether 2 filings, all relating to 28 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 30 July 2026, reports a share grant in PTC Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hege Elisabeth Sollie-Zetlmayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares0Common StockSEC:0002142653-26-000004:0
- 2,000 shares0Common StockSEC:0002142653-26-000004:1
2 of 2 declarations
